thetaOwl

NVDA

NVIDIA CorporationClose $212.45EOD only
Max Pain
$205.00
Next expiry Jun 17, 2026
Expected Move
±$4.66
2.2% from close
Price Gap
-7.45
Distance to max pain
IV Rank
74
High premium
P/C OI
0.88
Slightly call-heavy
Consensus
7.5/10
Bullish tilt
Published snapshot: Jun 15, 2026 close
End-of-day snapshot

This page reflects NVDA options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 15, 2026 close
NVDA AI Consensus Report
Analysis based on market close June 16, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
8.0

out of 10

8 not 9 because the pinning thesis conflicts with breakout expectation, creating timing uncertainty; high confidence in pinning but lower on upside follow-through.

Where Perspectives Agree

All personas agree on a bullish pin near $208 with strong dealer gamma ($509M) and bullish flow, but near-term upside capped by max pain.

Where They Diverge

Directional expects breakout to $217, while earnings and flow highlight pinning at $208; also earnings far out (71 days) reduces catalyst urgency, conflicting with directional's immediate bullish continuation.

Top Trade
via theta

Sell 2026-08-21 $200/$195 put spread for $1.50 credit

Key Risk

Break below $200 flips dealer gamma long, removing pinning support and accelerating downside to next gamma level near $190.

How to Use These Reports
This ai consensus reflects the market close on June 16, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.